Contract W58P0522C0009

Ihealth Labs Inc. · Department Of Defense · January 13, 2022

Firm Fixed PriceFull & Open CompetitionNAICS 325413

Ihealth Labs Inc. was awarded a federal contract by Department Of Defense (Department Of The Army) on January 13, 2022 for $1.77 billion of work in in-vitro diagnostic substance manufacturing. Performance is in Sunnyvale, CA. It was awarded under full and open competition. The contract has been modified 4 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on June 27, 2022.

Obligated to date
$1.77B
$1,774,999,987
Current value
$1.77B
Potential value
$1.84B
if all options exercised
Modifications
4
Latest June 27, 2022

Contract details

PIID
W58P0522C0009
Award type
Definitive Contract
Pricing
Firm Fixed Price
Set-aside
No Set Aside Used.
Competition
Full And Open Competition After Exclusion Of Sources
NAICS
325413 · In-Vitro Diagnostic Substance Manufacturing
Product / service
Medical And Surgical Instruments, Equipment, And Supplies
Place of performance
Sunnyvale, CA
First action
January 13, 2022
Latest action
June 27, 2022

Description

COVID-19 ANTIGEN OTC TEST KITS

Modification timeline

  • June 27, 2022
    Mod P00004
    $0
  • March 14, 2022
    Mod P00003
    ADMIN MOD TO CORRECT CLERICAL ERROR AND EXTEND CLIN 0005 TO 31 MAR 2022 IAW GOV DIRECTION.
    $-5
  • March 3, 2022
    Mod P00002
    $0
  • January 26, 2022
    Mod P00001
    $500.00M
  • January 13, 2022
    Base award
    COVID-19 ANTIGEN TEST
    $1.27B

Similar contracts

RecipientAgencyDateObligated
Diasorin IncDepartment Of DefenseDecember 31, 2025$518.8K
BloodworksDepartment Of DefenseDecember 31, 2025$160.2K
Sl Meditech Co.Department Of DefenseDecember 31, 2025$151.6K
Alba Bioscience, Inc.Department Of DefenseDecember 31, 2025$163.2K
Werfen USA LlcDepartment Of DefenseDecember 31, 2025$18.1K
Immucor IncDepartment Of DefenseDecember 31, 2025$154.2K

Top contractors in NAICS 325413

Lifetime obligated dollars across all federal contracts in this NAICS code.

#ContractorContractsObligated
1Abbott Rapid Dx North America Llc651$3.51B
2Ihealth Labs Inc.4$2.13B
3Roche Diagnostics Corporation5,604$959.60M
4Siemens Healthcare Diagnostics Inc.818$641.45M
5Cepheid3,693$639.45M
6Remel Inc.4,525$464.47M
7Access Bio, Inc.5$340.72M
8Ortho-Clinical Diagnostics, Inc1,964$227.77M
9Quidel Corp96$194.78M
10Ortho-Clinical Diagnostics Inc2,494$183.46M

Track this on BesaGov

Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.

✓ You’re on the list. We’ll never spam you.

Helpful guides

Continue learning

See all guides →
More on BesaGov

Keep researching

Track this contract, set alerts on similar opportunities, and build proposal pipelines on BesaGov.
Sign up free

Frequently asked questions

What is contract W58P0522C0009?

Contract W58P0522C0009 is a federal contract awarded to Ihealth Labs Inc. by Department Of Defense on January 13, 2022 for $1.77 billion of work classified under IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING. It has been modified 4 times since the base award.

Who won contract W58P0522C0009?

Ihealth Labs Inc. won contract W58P0522C0009 from Department Of Defense.

How much is contract W58P0522C0009 worth?

Contract W58P0522C0009 has obligated $1.77 billion to date, with a total potential value of $1.84 billion if all options are exercised.